Home
Membership
Members' Area
Get Involved
Conferences
Events
Education
Science Policy
Publications
Grants
Awards
About Us


Annual Symposium: Epigenetic mechanisms in development and disease

11—13 December 2012

University of Leeds, UK



Meeting background

Epigenetic mechanisms, including the posttranslational modifications of chromatin (DNA and histones), play pivotal roles in development, cell differentiation and cell identity. Inappropriate regulation of epigenetic mechanisms has been implicated in common human diseases such as diabetes, neuropsychiatric disorders and cancers. Environmental influences such as nutrition and stress can lead to epigenetic alterations and contribute to chronic disease biology.


Since the original epigenetic mark on DNA, cytosine methylation, was discovered there has been many posttranslational marks on histone proteins shown to have a functional impact on controlling gene expression in development and disease processes. Much progress has been made in understanding the biochemistry of such modifications though there is still far to go before we understand the functional impact and combinatorial roles of the modifications within an organism. Recent advances in technology have made genome-wide of studies of modifications feasible providing rich datasets on the epigenomes of individual cell states.


This meeting will encompass our current understanding of the role of cytosine methylation, as well histone modifications and the recently identified cytosine hydoxymethylation. There will be a focus on understanding how epigenetic marks regulate development and normal physiological functions in addition to the contribution they make to disease progression. The use of new technologies to interrogate epigenetic landscapes and their potential for future discoveries will be also be highlighted.
 

Organizers:
Adele Murrell (Cancer Research UK, United Kingdom)
Paul Hurd (Queen Mary, University of London, United Kingdom)
Ian Wood (University of Leeds, United Kingdom)

Session 1

 

Chair:
Steve Busby (University of Birmingham, United Kingdom)
11:00 - 12:50 Registration with lunch

12:50 - 13:00
Welcome and introduction
The Organizers
13:00 - 14:00
DNA methylation and MecP2 in Rett syndrome
Adrian Bird (The Wellcome Trust Centre for Cell Biology, United Kingdom)
14:00 - 14:40
Intergenerational epigenetic programming in a mouse model of undernutrition
Anne Ferguson-Smith (University of Cambridge, United Kingdom)
14:40 - 15:10 Coffee/tea break

Session 2

 

Chair:
Ian Wood (University of Leeds, United Kingdom)
15:10 - 15:45
Epigenetic regulation of placental endocrine lineages and complications of pregnancy
Rosalind John (Cardiff University, United Kingdom)
15:45 - 16:20
Molecular mechanisms of developmental epigenetic reprogramming
Petra Hajkova (MRC Clinical Sciences Centre, United Kingdom)
16:20 - 17:00 Flash poster presentation


Session 3

 

Chair:
Paul Hurd (Queen Mary, University of London, United Kingdom)
19:00 - 20:00
Epigenetics – creating new medicines from the missing link between nature and nurture
Public lecture - Nessa Carey (Pfizer, United Kingdom)
20:00 Dinner

Session 4

 

Chair:
Adele Murrell (Cancer Research UK, United Kingdom)
09:00 - 09:35
Epigenetic reprogramming in mammalian development
Wolf Reik (Babraham Institute, United Kingdom)
09:35 - 10:10
The importance of imprinted gene expression dosage in brain function and neurodevelopmental disease
Anthony Isles (University of Cardiff, United Kingdom)
10:10 - 10:30
CpG dinucleotide-specific variations in Tensin gene promoter methylation in human renal cell carcinoma
Selected oral communication - Jessica Carter (University of Portsmouth, United Kingdom)
10:30 - 10:50
The potential for acquisition of 5-hmC is protective against DNA methylation change in colorectal neoplasia
Selected oral communication - Santiago Uribe-Lewis (Cambridge University - CRUK, United Kingdom)
10:50 - 11:20 Coffee/tea break

Session 5

 

Chair:
Steve Busby (University of Birmingham, United Kingdom)
11:20 - 12:10
Award Lecture
Epigenetic pathways and their role in cancer
Tony Kouzarides (The Gurdon Institute, United Kingdom)
12:10 - 14:00 Lunch with poster viewing

Session 6

 

Chair:
Paul Hurd (Queen Mary, University of London, United Kingdom)
14:00 - 14:35
Interpreting the CpG island signal
Rob Klose (University of Oxford, United Kingdom)
14:35 - 15:10
­­­Histone deacetylase (HDAC) 1 and 2 are essential for normal T cell development and genomic stability in mice
Shaun Cowley (University of Leicester, United Kingdom)
15:10 - 15:30
The enhancer of zest homology (EZH2) enzyme modulates angiogenesis in the setting of cellular hypoxia and in vivo muscular ischemia
Selected oral communication - Tijana Mitic (University of Bristol, Bristol Heart Institute, United Kingdom)
15:30 - 16:00 Coffee/tea break

Session 7

 

Chair:
Ian Wood (University of Leeds, United Kingdom)
16:00 - 16:35
Mechanisms of histone modification crosstalk during gene regulation
Antonis Kirmizis (University of Cyprus, Cyprus)
16:35 - 17:10
Chromatin control by prolyl-isomerases
Chris Nelson (University of Victoria, Canada)
17:10 - 17:30
Investigation of the role of histone deacetylases in rheumatoid arthritis synovial fibroblasts
Selected oral communication - Sarah Hawtree (University of Sheffield, United Kingdom)
17:30 - 17:50
The role of H3K9 demethylases in cardiac hypertrophy
Selected oral communication - Asmita Tingare (Babraham Institute, United Kingdom)

19:30 Conference dinner

Session 8

 

Chair:
Adele Murrell (Cancer Research UK, United Kingdom)
09:00 - 09:35
Hallmarks of cancer revisited: What about infection and epigenetics?
Stephan Beck (University College London, United Kingdom)
09:35 - 10:10
Transgenerational inheritance of non-genetically determined phenotypes
Vardhman Rakyan (Barts and The London School of Medicine and Dentistry, United Kingdom)
10:10 - 10:30
A pancreatic islet-specific long non-coding RNA (lncRNA) positively regulates Pdx1
Selected oral communication - Timothy Pullen (Imperial College London, United Kingdom)
10:30 - 11:00 Coffee/tea break

Session 9

 

Chair:
Paul Hurd (Queen Mary, University of London, United Kingdom)
11:00 - 11:35
Transcriptional control of lineage commitment in embryonic stem cells
Brian Hendrich (University of Cambridge, United Kingdom)
11:35 - 12:10
Mechanisms underlying TET-mediated hydroxymethylation in transcriptional regulation
François Fuks (Université Libre de Bruxelles, Belgium)
12:10 - 12:30
Do age-related diseases develop in cells which are pre-primed by the presence of aberrant patterns of DNA methylation?
Selected oral communication - Sanne van Otterdijk (Newcastle University, United Kingdom)
12:30 - 12:50
Investigating germ line epigenetic reprogramming in the rat
Selected oral communication - Catherine Rose (University of Edinburgh, United Kingdom)
12:50 - 14:00 Lunch and close of conference